The nucleotide sequence and the deduced amino acid sequence for the genes encoding the structural proteins of two strains of dengue virus type 2 (DEN-2) were determined from cDNA clones. The genes for C, prM(M) and E proteins were sequenced for the prototype DEN-2 virus, the New Guinea C strain. Also sequenced were the prM(M) and E genes of PUO-218. This strain of DEN-2 was isolated during 1980 in Bangkok and had received a limited number of laboratory passages.
Short communication
The NGC strain of virus, isolated in 1944 (Sabin & Schlesinger, 1945) , was chosen for sequencing as it is the prototype DEN-2 strain and has better characterized polypeptides than any other DEN-2 strain (Smith & Wright, 1985; Biedrzycka et al., 1987) . For the experiments reported here, NGC virus was obtained from Dr B. Gorman at the Queensland Institute of Medical Research (QIMR; Bramston Terrace, Herston, Brisbane, Australia). The virus used to infect Vero cells had been passaged 24 times through suckling mice, plaque-purified twice in equine kidney (EK) cells, passaged a further three times in EK cells and twice in Aedes albopictus C6/36 cells. The PUO-218 strain of virus was originally isolated from a 21 month old child with a symptomatic primary DEN-2 infection by Dr D. S. Burke during the 1980 dengue epidemic in Bangkok. The virus was isolated from plasma by inoculation into Toxorhynchites splendens mosquitoes. Mosquito thorax-abdomen suspensions were passed once in LLC-MK2 cells (D. S. Burke, personal communication; Morens et aL, 1987) . We obtained this virus from QIMR also, and grew the virus in C6/36 cells without further plaque purification.
Virus was purified by precipitation with polyethylene glycol and sedimentation through sucrose gradients (Smith & Wright, 1985) . The synthesis of cDNA for NGC starting with virion RNA and random primers, the cloning of viral inserts into plasmid pUC8, and the sequencing of the inserts by the chain termination method were as described by Biedrzycka et al. (1987) . Similar procedures were used for PUO-218, except that a deoxyoligonucleotide primer complementary to 15 bases at the start of the NS1 gene was used to prime first strand cDNA synthesis.
The nucleotide sequence and the deduced amino acid sequence for the region of the NGC genome encoding the C, prM(M), and E proteins are shown in Fig. 1 . The nucleotide sequence was determined from a series of overlapping clones ranging in size from 0-2 to 1.1 kb. Thirtyeight percent of the nucleotide sequence was determined from at least two independently isolated clones, and nucleotides 1637 to 1667 were determined by direct dideoxy nucleotide chain termination sequencing of virion RNA. Nucleotide 1 in the NGC sequence shown corresponds to nucleotide 77 counting from the 5' end of the DEN-2 (JAM) sequence (Deubel et al., 1986) . The nucleotide sequence for PUO-218 has been determined for the region encoding the carboxy terminus of C and all of prM and E; alignment of this sequence with the NGC sequence is also shown in Fig. 1 . The sequence of PUO-218 was obtained predominantly from a single cDNA clone of 2.1 kb. Five percent of the sequence was determined from a second clone (0.6 kb) located at the 3' end of the E gene. Forty-five percent of the sequence was determined from both strands of the cDNA. Nucleotides identical in NGC and PUO-218 are indicated by dots. The start points of E and NS1 for DEN-2 have been determined by amino acid sequencing of the viral proteins (Bell et al., 1985; Biedrzycka et al., 1987) , whereas the amino termini of C, prM and M have been assigned by alignment with other flavivirus proteins (Castle et al., 1985; Deubel et al., 1986) .
A comparison of the deduced amino acid sequences of the structural proteins for the strains NGC, PUO-218, JAM (Deubel et al., 1986) and S1 (Hahn et al., 1988) is provided in Fig. 2 . Some calculations for similarities at the amino acid and nucleotide levels generated by pairwise comparisons between the strains are summarized in Tables 1 and 2 . A comparison between the NGC, S1 and JAM strains for the entire structural region (Table l) indicated that NGC and JAM are more closely related to each other than S 1 is to either of them. Analysis of the E region alone, including strain PUO-218 (Table 2) , also demonstrated the dissimilarity of $1 to the other strains because the percentage similarities in pairwise comparisons were lowest in those involving the S 1 strain i.e. 91.9 ~, 90.8 ~, 91.1 ~ (nucleotides) and 97-6 ~, 97-6 ~, 97.2 ~ (amino acids). The most similar pair of strains was NGC and PUO-218 (96-2~ nucleotides, 98.8~ amino acids) followed closely by NGC and JAM (96.1~ nucleotides, 98.4~ amino acids) .
Further analysis of the data presented in Fig. 1 revealed that the longest stretch of conserved nucleotides in NGC and PUO-218 runs from nucleotide 819 to nucleotide 1015, a region that encodes the amino-terminal portion of E. It is intriguing to note that NGC nucleotides 820 to 946 inclusive are also conserved in the JAM strain, and that this is also the longest conserved stretch observed when the nucleotide sequences for the structural genes of the NGC and JAM strains are compared (detailed analysis not shown). However, a comparison of NGC and S1 Within the primary structure ofprM and E for the four DEN-2 strains, potential glycosylation sites at prM-69, E-67 and E-153 are conserved (Fig. 2) . The presence of one glycosylation site in prM and two in E is consistent with the estimates obtained for the number of N-linked glycans contained in each of these glycoproteins (Smith & Wright, 1985) . Eighteen cysteine residues are conserved. Also conserved in E are three peptides underlined in Fig. 2 ; they are peptides E-98 to E-111, E-371 to E-378 and E-416 to E-422. These peptides are conserved in St Louis encephalitis, West Nile, Murray Valley encephalitis, yellow fever (17D), Kunjin and DEN-2 viruses (Trent et al., 1987; Coia et al., 1988) . It has been suggested that these peptides may be involved in important biological functions such as binding to cell receptors or membrane fusion (Deubel et al., 1986; Hahn et al., 1987) .
In the prM and E proteins of the NGC strain there are two amino acid substitutions which are not found in any of the other three strains. Isoleucine rather than phenylalanine, another nonpolar amino acid, is located at E-402; the basic amino acid lysine rather than glutamic acid is at E-126. The nucleotide sequence for the first conservative substitution was obtained from a single clone. However, the sequence for the second substitution was obtained from two independently isolated clones, indicating that it is unlikely to be the result of a cloning artefact. For PUO-218, unique amino acids are located at prM-125, E-141 and E-164; they involve changes of isoleucine for threonine, or of valine for isoleucine.
Similar conservative interchanges are observed elsewhere in Fig. 2 . At present it is not possible to assess the effect of any of these amino acid changes on the structure and function of prM and E, due to lack of information on the three-dimensional structures of the proteins and on the locations of important functional domains.
Trent and his colleagues have assigned DEN-2 isolates from different geographic regions to at least six groups of genetic variants or topotypes by mapping of oligonucleotides following digestion of genomic RNA with RNase T1 (Trent et al., 1983; Monath et al., 1986; Kerschner et al., 1986) . A major aim of their studies has been to facilitate the identification of virus strains involved in outbreaks of disease. In general, the topotype groupings of the viruses were confirmed by antigen signature analysis . Our analyses of sequence data provide yet another way of comparing isolates. The results for the E region, which represents only 14~ of the whole genome, indicate a close relationship between PUO-218 and NGC, and 
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. Fig. 2 . A comparison of the deduced amino acid sequences for structural proteins specified by four strains of DEN-2 virus. Potential glycosylation sites are indicated by asterisks. Underlined peptides are highly conserved in the flaviviruses sequenced so far. The amino acid sequences for the SI and JAM strains are from Hahn et al. (1988) and Deubel et al. (1986) , respectively, between JAM and NGC. The four strains whose structural regions we have compared differ in geographic origin, date of isolation and passage history. The similarities between the four strains based on this part of the genome (Tables 1 and 2 ) do not closely follow the geographic region of isolation, e.g. Caribbean (JAM, S1) and S.E. Asia (NGC, PUO-218), or time of isolation, e.g. early [NGC (1944) , S1 (1969) ] and late [PUO-218 (1980) , JAM (1983) ] or the number of passages, e.g. high (NGC, S1) and low (JAM, . However, the most divergent strain is apparently S1, which has been extensively passaged in cell culture, is a small plaque and temperature-sensitive virus, and is attenuated in rhesus monkeys (Eckels et al., 1976; Harrison et al., 1977) . In order to relate changes at the molecular level to differences in virulence of virus strains, it is now important to obtain further comparisons of attenuated strains such as S 1 with low passage field isolates associated with defined disease outbreaks.
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